<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Iran J Psychiatry Behav Sci</journal-id><journal-id journal-id-type="iso-abbrev">Iran J Psychiatry Behav Sci</journal-id><journal-id journal-id-type="doi">10.17795/ijpbs</journal-id><journal-id journal-id-type="publisher-id">Mazandaran University of Medical Sciences</journal-id><journal-title-group><journal-title>Iranian Journal of Psychiatry and Behavioral Sciences</journal-title></journal-title-group><issn pub-type="ppub">1735-8639</issn><issn pub-type="epub">1735-9287</issn><publisher><publisher-name>Mazandaran University of Medical Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26251659</article-id><article-id pub-id-type="pmc">4525448</article-id><article-id pub-id-type="doi">10.17795/ijpbs216</article-id><article-categories><subj-group subj-group-type="heading"><subject>Brief Report</subject></subj-group></article-categories><title-group><article-title>Comparing Mindfulness-Based Group Therapy With Treatment as Usual for Opioid Dependents: A Pilot Randomized Clinical Trial Study Protocol</article-title></title-group><contrib-group><contrib id="idp9726032" contrib-type="author"><name><surname>Imani</surname><given-names>Saeed</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib id="idp10010848" contrib-type="author"><name><surname>Atef Vahid</surname><given-names>Mohammad Kazem</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib id="idp9732848" contrib-type="author"><name><surname>Gharraee</surname><given-names>Banafsheh</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib id="idp9732240" contrib-type="author"><name><surname>Habibi</surname><given-names>Mojtaba</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib id="idp9731632" contrib-type="author"><name><surname>Bowen</surname><given-names>Sarah</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib id="idp9736448" contrib-type="author"><name><surname>Noroozi</surname><given-names>Alireza</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="corresp" rid="idp10669504">*</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Department of Clinical Psychology, Shahid Beheshti University, Tehran, IR Iran</aff><aff id="aff2"><label>2</label>Department of Clinical Psychology, Tehran Psychiatric Institute, Iran University of Medical Sciences, Tehran, IR Iran</aff><aff id="aff3"><label>3</label>Family Research Institute, Shahid Beheshti University, Tehran, IR Iran</aff><aff id="aff4"><label>4</label>Addictive Behaviors Research Center, Department of Psychology, University of Washington, Seattle, USA</aff><aff id="aff5"><label>5</label>Iranian National Center for Addiction Studies, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, IR Iran</aff><aff id="aff6"><label>6</label>School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, IR Iran</aff><author-notes><corresp id="idp10669504"><label>*</label>Corresponding author: Alireza Noroozi, Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, IR Iran. Tel: +98-21-55421144, E-mail: <email>a_r_noroozi@yahoo.com</email></corresp></author-notes><pub-date pub-type="epub"><day>07</day><month>3</month><year>2015</year></pub-date><pub-date pub-type="ppub"><month>3</month><year>2015</year></pub-date><volume>9</volume><issue>1</issue><elocation-id>e216</elocation-id><history><date date-type="received"><day>11</day><month>1</month><year>2014</year></date><date date-type="rev-recd"><day>24</day><month>10</month><year>2014</year></date><date date-type="accepted"><day>29</day><month>1</month><year>2015</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2015, Mazandaran University of Medical Sciences.</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/"><license-p><!--CREATIVE COMMONS-->This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Background:</title><p>In response to high burden of opioid abuse in Iran, Ministry of Health has launched a large-scale opioid maintenance treatment program, delivered through a network of certified drug treatment centers. To promote opioid pharmacotherapies, there is an urgent need to develop and introduce evidence-based psychosocial interventions into the network.</p></sec><sec><title>Patients and Methods:</title><p>This is a randomized clinical trial (RCT) to investigate feasibility and effectiveness of adding mindfulness-based group therapy to opioid pharmacotherapies as compared to opioid pharmacotherapies alone. The primary outcomes were treatment retention and percentage of weekly morphine, methamphetamine, and benzodiazepine negative tests.</p></sec><sec><title>Discussion:</title><p>This is the first RCT that explores the effectiveness of mindfulness-based relapse prevention group therapy among opioid dependent clients in Iran. The feasibility of group therapy and comparison of outcomes in intervention and control groups should be discussed in the outcome article.</p></sec></abstract><kwd-group kwd-group-type="author"><kwd>Mindfulness</kwd><kwd>Pharmacotherapies</kwd><kwd>Therapy</kwd></kwd-group></article-meta></front><body><sec><title>1. Introduction</title><p>Iran has a long and hard-to-control border with Afghanistan, the main producer of illegal opiates in the world. Across this border opioid drugs are smuggled into the luxurious drug markets of European countries (<xref rid="A216REF1" ref-type="bibr">1</xref>). According to a national epidemiologic study conducted by Ministry of Health, there are more than 1.2 million opioid dependents in the country (<xref rid="A216REF2" ref-type="bibr">2</xref>). A more recent study estimated the number of drug dependents by indirect methods at 1.2 million that most of them were opioid users (<xref rid="A216REF3" ref-type="bibr">3</xref>). A rapid change in opiate use patterns during recent years from opium to heroin and from smoking to injection has made the opioid dependence epidemic more problematic (<xref rid="A216REF4" ref-type="bibr">4</xref>). Using unsterile syringe and injection equipment is the most prevalent route (69.2%) of HIV transmission among all registered HIV positive cases (<xref rid="A216REF5" ref-type="bibr">5</xref>). To respond to HIV epidemic among people who inject opioid, the methadone maintenance treatment was launched in 2002 and scaled up rapidly across the country.</p><p>Currently, opioid maintenance, treatment programs, and short-term medically assisted withdrawals are delivered through a network of certified drug treatment centers. Furthermore, opioid maintenance treatment could successfully decrease cue-induced cravings among opioid users (<xref rid="A216REF6" ref-type="bibr">6</xref>), however, they are less effective in reducing stress-induced cravings (<xref rid="A216REF7" ref-type="bibr">7</xref>). Hypothetically, new approaches of psychotherapies that focus on mindfulness and acceptance might enhance anti-craving properties of opioid maintenance treatment through reducing stress-induced cravings. Mindfulness-based therapies are new approaches in psychotherapy that integrate spiritual traditions such as mindfulness meditation with classic behavioral therapy approaches (<xref rid="A216REF8" ref-type="bibr">8</xref>). Mindfulness helps clients to learn how to monitor their own mental processes free of judgment and without being caught up in the actual content of their thoughts. The core skill in mindfulness is the capacity to respond to aversive cognitions, sensations, and emotions with greater acceptance, present moment awareness, and a nonjudgmental attitude (<xref rid="A216REF9" ref-type="bibr">9</xref>). Through mindfulness practices, the content of the thought becomes less important than the extent of the individual&#x02019;s awareness and reaction to it and its occurrence (<xref rid="A216REF9" ref-type="bibr">9</xref>).</p><p> Mindfulness-based therapies have proved to be effective in a wide range of physical and psychological problems such as chronic pain (<xref rid="A216REF10" ref-type="bibr">10</xref>), depression, anxiety, and stress among college students (<xref rid="A216REF11" ref-type="bibr">11</xref>) or people with subarachnoid hemorrhage (<xref rid="A216REF12" ref-type="bibr">12</xref>), psychosocial stress (<xref rid="A216REF13" ref-type="bibr">13</xref>), and depression (<xref rid="A216REF14" ref-type="bibr">14</xref>), as well as distinct psychiatric disorders, including hypochondriasis (<xref rid="A216REF15" ref-type="bibr">15</xref>), social phobia (<xref rid="A216REF16" ref-type="bibr">16</xref>), generalized anxiety disorder (<xref rid="A216REF17" ref-type="bibr">17</xref>), obsessive-compulsive disorders (<xref rid="A216REF18" ref-type="bibr">18</xref>), and somatization disorder (<xref rid="A216REF19" ref-type="bibr">19</xref>). Mindfulness-based relapse prevention (<xref rid="A216REF20" ref-type="bibr">20</xref>) is a program integrating mindfulness meditation practices with traditional relapse prevention (RP). The program was tested and proved its effects in decreasing relapses in different groups of drug users, (<xref rid="A216REF21" ref-type="bibr">21</xref>). Similar mindfulness-based programs for substance abuse have been shown to increase compliance, cognitive control, regulation of emotions, and reduce stress in alcohol dependents (<xref rid="A216REF22" ref-type="bibr">22</xref>, <xref rid="A216REF23" ref-type="bibr">23</xref>) as well as some other similar influences (<xref rid="A216REF24" ref-type="bibr">24</xref>).</p><p>The effectiveness of mindfulness in different populations of drug users suggests that more trials (in which the type of &#x02018;Mindfulness-based Group Therapy&#x02019; was clearly defined and described) were required to establish the efficacy of Mindfulness-based Group Therapy for opioid dependence treatments.</p></sec><sec><title>2. Patients and Methods</title><p>This study was a pilot, randomized, parallel group, one to one controlled trial investigating feasibility, acceptability and effectiveness of mindfulness-based group therapy to improve treatment outcomes in opioid dependent clients.</p><sec><title>2.1. Inclusion Criteria</title><p>The opioid dependent clients receiving treatment as usual in Iranian National Center for Addiction Studies (INCAS) were randomly assigned to intervention and control groups. INCAS Clinic is located in southwest of Tehran, Iran and provides assisted withdrawal and maintenance treatment with opioid agonist medications, including methadone and buprenorphine for its opioid dependent clients (96.6% male). Inclusion criteria were as follows: (1) diagnosis of opioid dependence according to DSM-IV-TR criteria, (2) age range 18 to 40 years, (3) at least 8 years of completed education (<xref rid="A216REF5" ref-type="bibr">5</xref>), stabilization on medical treatment (4), and informed written consent for participation in the study. The exclusion criteria were psychosis, dementia, imminent suicide risk, organic brain disorders, diagnosis of other drug dependence (except nicotine), or non-stabilization on 2-week medical treatments.</p></sec><sec><title>2.2. Content of the Interventions</title><p>Intervention was a combination of 8-session mindfulness-based group therapy developed by Bowen et al. and the usual treatment provided to opioid dependents in INCAS clinic (<xref ref-type="fig" rid="A216FIG1">Figure 1</xref>). The study was designed in a manner to be comparable to other studies of mindfulness-based group therapy for addiction treatment. There was an English manual available to deliver the intervention (<xref rid="A216REF20" ref-type="bibr">20</xref>), which described it as a structured intervention. One of the authors translated the manual to Farsi, which was edited by an addiction expert with a PhD in clinical psychology. The therapy sessions held in a closed-group format and conducted on a weekly basis. Each session lasted 120 minutes. It was a structured intervention with a predefined title and content for each session, and the sessions were kept in sequence. <xref ref-type="table" rid="A216TBL1">Table 1</xref> outlines an overview of the topics and themes that were covered in each session. Although each session had a central theme, the sessions were intended to build upon previous week&#x02019;s practices.</p><fig id="A216FIG1" fig-type="inline" orientation="portrait" position="float"><label>Figure 1.</label><caption><title>Consort Diagram of the Study</title></caption><ext-link ext-link-type="uri" xlink:href="http://cdn.neoscriber.org/cdn/serve/85/78/857806605b5e1a12ef3e979c5a544f6f26205dad/ijpbs-09-01-216-i001.eps"/><graphic xlink:href="ijpbs-09-216-i001"/></fig><table-wrap id="A216TBL1" orientation="portrait" position="float"><label>Table 1.</label><caption><title>Mindfulness-based Relapse Prevention Group Therapy Sessions</title></caption><table frame="hsides" rules="groups"><thead><tr><th style="text-align: left;" rowspan="1" colspan="1">Session</th><th rowspan="1" colspan="1">Central Theme</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<bold>1</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">Automatic pilot and relapse</td></tr><tr><td rowspan="1" colspan="1">
<bold>2</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">Awareness of triggers and cravings</td></tr><tr><td rowspan="1" colspan="1">
<bold>3</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">Mindfulness in daily life</td></tr><tr><td rowspan="1" colspan="1">
<bold>4</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">Mindfulness in high risk situations</td></tr><tr><td rowspan="1" colspan="1">
<bold>5</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">Acceptance and skillful actions</td></tr><tr><td rowspan="1" colspan="1">
<bold>6</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">Seeing thoughts as thoughts</td></tr><tr><td rowspan="1" colspan="1">
<bold>7</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">Self-care and lifestyle balance</td></tr><tr><td rowspan="1" colspan="1">
<bold>8</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">Social support and continuing practice</td></tr></tbody></table></table-wrap><p>All study participants received medical treatment through opioid agonist medications in outpatient INCAS clinic according to national protocols (<xref rid="A216REF25" ref-type="bibr">25</xref>). The methadone or buprenorphine administration was conducted through regular visits by certified physicians that were more frequent during the first week of treatment and gradually decreased to at least one visit per week. Clients who received maintenance treatment should have come to the clinics for daily supervised dosing during the first two months of treatment. The take-home doses were allowed 1 d/wk from the beginning of the third month, which could increase from 1 d/mon to at most 6 d/wk contingent to appropriate compliance and negative weekly urine tests for morphine and methamphetamine. The baseline, weekly, and end of the treatment study assessments are presented in <xref ref-type="table" rid="A216TBL2">Table 2</xref>.</p><table-wrap id="A216TBL2" orientation="portrait" position="float"><label>Table 2.</label><caption><title>Assessment Instruments Proposed for the Current Study</title></caption><table frame="hsides" rules="groups"><thead><tr><th style="text-align: left;" rowspan="1" colspan="1">Instrument</th><th rowspan="1" colspan="1">Baseline</th><th rowspan="1" colspan="1">Weekly</th><th rowspan="1" colspan="1">8 Weeks Follow up</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<bold>Log sheet of treatment participation</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1">&#x0221a;</td><td style="text-align: center;" rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">
<bold>Urine drug testing for morphine, methamphetamine, and benzodiazepines</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">&#x0221a;</td><td style="text-align: center;" rowspan="1" colspan="1">&#x0221a;</td><td style="text-align: center;" rowspan="1" colspan="1">&#x0221a;</td></tr><tr><td rowspan="1" colspan="1">
<bold>Addiction Severity Index (</bold><xref rid="A216REF26" ref-type="bibr">26</xref><bold>)</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">&#x0221a;</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1">&#x0221a;</td></tr><tr><td rowspan="1" colspan="1">
<bold>Alcohol and drug cravings (</bold><xref rid="A216REF27" ref-type="bibr">27</xref><bold>)</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">&#x0221a;</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1">&#x0221a;</td></tr><tr><td rowspan="1" colspan="1">
<bold>DASS-21 (</bold><xref rid="A216REF19" ref-type="bibr">19</xref><bold>)</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">&#x0221a;</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1">&#x0221a;</td></tr><tr><td rowspan="1" colspan="1">
<bold>Mindfulness (</bold><xref rid="A216REF28" ref-type="bibr">28</xref><bold>)</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">&#x0221a;</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1">&#x0221a;</td></tr><tr><td rowspan="1" colspan="1">
<bold>Acceptance (</bold><xref rid="A216REF8" ref-type="bibr">8</xref><bold>)</bold>
</td><td style="text-align: center;" rowspan="1" colspan="1">&#x0221a;</td><td style="text-align: center;" rowspan="1" colspan="1"/><td style="text-align: center;" rowspan="1" colspan="1">&#x0221a;</td></tr></tbody></table></table-wrap></sec><sec><title>2.3. Sample Size Calculation</title><p>The study participants recruited in INCAS in the autumn of 2013. Thirty eligible individuals were selected randomly for participation in the study; 15 of them were assigned to each intervention group. In order to have consistency in seasonality across assessment points, the assessment obtained in the autumn of 2013 served as the baseline or pretest assessment point for the main substantive intervention outcome analysis and the winter of 2013 assessment served as the outcome time point for the analysis report; hence, this was an experimental research design.</p></sec><sec><title>2.4. Statistical Analysis</title><p>To determine legitimate numerical codes, data cleaning was performed by both graphical and descriptive statistics to ensure data accuracy, check out-of-range values for categorical variables, and make sure that mean and standard deviations were within the plausible ranges for continuous composite variables (<xref rid="A216REF29" ref-type="bibr">29</xref>). The patterns of missing data were checked regarding how much and why they were missing. Results of SPSS MVA (missing values analysis) using t test (&#x003b1; = 0.05) for outcome composite variables were checked to ensure that patterns of missing data in outcome variables were not related to population&#x02019;s demographic variables such as sex, area of residency, and group (intervention vs. condition). Distribution of scores on continuous variables was checked for univariate (P &#x0003c; 0.001) and multivariate normality using LISREL, version 8.72 (<xref rid="A216REF30" ref-type="bibr">30</xref>). T test and chi-square test were conducted to match the intervention and control groups with respect to demographic variables. Repeated measure analysis of variance was used to test the effectiveness of mindfulness-based group therapy in the study population.</p></sec></sec><sec><title>3. Discussion</title><p>To the best of our knowledge, this is the first study to test the acceptability and efficacy of &#x02018;Mindfulness-based Group Therapy&#x02019; versus &#x02018;Treatment as Usual&#x02019; for opioid dependent clients in Iran. There are some potential limitations regarding the present study that merit discussion. One potential concern is the random assign of the participants to their study condition, which may lead to realize whether or not they are receiving the added group therapy. When the participants prefer one group to the other, this might disappoint them, which may negatively affect the treatment outcome. However, since the study intended to investigate the effect of adding the mindfulness-based group therapy to treatment as usual, the current design remains most appropriate as it is closer to a real world situation. After the mindfulness-based group therapy session, the study participants were advised to report their participation in self-help programs during the course of the therapy. As it is not possible to monitor participants&#x02019; behavior during this period, self-reports about their use of other treatment programs should be trusted. Throughout the recruitment, the mindfulness-based group therapy sessions and its follow-ups, it was emphasized to the participants that their honest information was crucial and there would be no consequences if they participated in other methods. It is hoped that by conveying this message to the participants, they were motivated to cooperate throughout the study and provide their honest reports about their experiences during study assessments. The results of the present study indicate whether mindfulness-based group therapy can improve the outcome of opioid dependence treatment in the context of Iran drug treatment services.</p></sec></body><back><ack><p>Authors acknowledge the close collaboration of Iranian National Center for Addiction Studies (INCAS) director and staff for their kind assistance.</p></ack><fn-group><fn fn-type="other" id="afn1"><p><bold>Authors&#x02019; Contributions:</bold>Saeed Imani prepared the first draft of the paper and coordinated the study. Mohammad Kazem Atef Vahid was the principal investigator, developed the study design and prepared the final draft of the paper. Alireza Noroozi, Banafsheh Gharraee, Mojtaba Habibi, and Sarah Bowen critically reviewed the study design and developed the analysis methods. All authors read and approved the final version of the manuscript.</p></fn><fn fn-type="supported-by" id="afn2"><p><bold>Funding/Support:</bold>The first author received a small grant from Tehran University of Medical Sciences (TUMS) to conduct the study as his PhD thesis. Other authors have not received any financial support for the study.</p></fn><fn fn-type="supported-by" id="afn3"><p><bold>Declaration of interest:</bold> None Declared.</p></fn></fn-group><ref-list><ref id="A216REF1"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>United Nation Office of Drug and Crime</collab></person-group><publisher-loc>Vienna</publisher-loc><publisher-name>UNODC Publications</publisher-name><source>World Drug Report .</source><year>2013</year></element-citation></ref><ref id="A216REF2"><label>2</label><element-citation publication-type="journal" publication-format="print"><article-title>Epidemiology of drug abuse in I.R. Iran.</article-title><person-group person-group-type="author"><name><surname>Yasami</surname><given-names>MT</given-names></name><name><surname>Shahmohammadi</surname><given-names>D</given-names></name><name><surname>Naghavi</surname><given-names>M</given-names></name><name><surname>Bagheri-Yazdi</surname><given-names>A</given-names></name><name><surname>Zojaji</surname><given-names>A</given-names></name><name><surname>Rahimi-Movaghar</surname><given-names>A</given-names></name></person-group><source>Ministry of Health and Drug Control Headquarters.</source><year>2002</year></element-citation></ref><ref id="A216REF3"><label>3</label><element-citation publication-type="journal" publication-format="print"><article-title>Substance-dependent professional drivers in Iran: a descriptive study.</article-title><fpage>227</fpage><issue>3</issue><lpage>30</lpage><person-group person-group-type="author"><name><surname>Narenjiha</surname><given-names>H</given-names></name><name><surname>Rafiey</surname><given-names>H</given-names></name><name><surname>Jahani</surname><given-names>MR</given-names></name><name><surname>Assari</surname><given-names>S</given-names></name><name><surname>Moharamzad</surname><given-names>Y</given-names></name><name><surname>Roshanpazooh</surname><given-names>M</given-names></name></person-group><pub-id pub-id-type="doi">10.1080/15389580902849017</pub-id><source>Traffic Inj Prev.</source><volume>10</volume><year>2009</year><pub-id pub-id-type="pmid">19452363</pub-id></element-citation></ref><ref id="A216REF4"><label>4</label><element-citation publication-type="journal" publication-format="print"><article-title>Transition to injection amongst opioid users in Iran: implications for harm reduction.</article-title><fpage>333</fpage><issue>4</issue><lpage>7</lpage><person-group person-group-type="author"><name><surname>Malekinejad</surname><given-names>M</given-names></name><name><surname>Vazirian</surname><given-names>M</given-names></name></person-group><pub-id pub-id-type="doi">10.1016/j.drugpo.2011.09.001</pub-id><source>Int J Drug Policy.</source><volume>23</volume><year>2012</year><pub-id pub-id-type="pmid">21996166</pub-id></element-citation></ref><ref id="A216REF5"><label>5</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Ministry of Health and Medical Education</collab></person-group><source>[Quarterly reported of statistics of HIV/AIDS Cases Ministry of Health and Medical Education, Center of Diseases Management, Sexually Transmitted Disease and AIDS Office].</source><year>2012</year></element-citation></ref><ref id="A216REF6"><label>6</label><element-citation publication-type="journal" publication-format="print"><article-title>Long-term methadone maintenance reduces protracted symptoms of heroin abstinence and cue-induced craving in Chinese heroin abusers.</article-title><fpage>141</fpage><issue>1</issue><lpage>5</lpage><person-group person-group-type="author"><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>LY</given-names></name><name><surname>Epstein</surname><given-names>DH</given-names></name><name><surname>Zhang</surname><given-names>XL</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name></person-group><pub-id pub-id-type="doi">10.1016/j.pbb.2007.04.010</pub-id><source>Pharmacol Biochem Behav.</source><volume>87</volume><year>2007</year><pub-id pub-id-type="pmid">17532034</pub-id></element-citation></ref><ref id="A216REF7"><label>7</label><element-citation publication-type="journal" publication-format="print"><article-title>The effect of stress on craving for methadone depends on the timing of last methadone dose.</article-title><fpage>1170</fpage><issue>10</issue><lpage>5</lpage><person-group person-group-type="author"><name><surname>Ilgen</surname><given-names>M</given-names></name><name><surname>Jain</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>HM</given-names></name><name><surname>Trafton</surname><given-names>JA</given-names></name></person-group><pub-id pub-id-type="doi">10.1016/j.brat.2008.05.013</pub-id><source>Behav Res Ther.</source><volume>46</volume><year>2008</year><pub-id pub-id-type="pmid">18675399</pub-id></element-citation></ref><ref id="A216REF8"><label>8</label><element-citation publication-type="journal" publication-format="print"><article-title>Measuring experiential avoidance: A preliminary test of a working model.</article-title><fpage>553</fpage><issue>4</issue><lpage>78</lpage><person-group person-group-type="author"><name><surname>Strosahl</surname><given-names>KD</given-names></name><name><surname>Wilson</surname><given-names>KG</given-names></name><name><surname>Bissett</surname><given-names>RT</given-names></name><name><surname>Pistorello</surname><given-names>J</given-names></name><name><surname>Toarmino</surname><given-names>D</given-names></name></person-group><source>Psychol Rec.</source><volume>54</volume><year>2004</year></element-citation></ref><ref id="A216REF9"><label>9</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Segal</surname><given-names>Z</given-names></name><name><surname>Williams</surname><given-names>JMG</given-names></name><name><surname>Teasdale</surname><given-names>J</given-names></name></person-group><publisher-loc>New York</publisher-loc><publisher-name>Guilford Press</publisher-name><source>Mindfulness-based cognitive therapy for depression.</source><year>2002</year></element-citation></ref><ref id="A216REF10"><label>10</label><element-citation publication-type="journal" publication-format="print"><article-title>Spirituality, mindfulness and substance abuse.</article-title><fpage>1335</fpage><issue>7</issue><lpage>41</lpage><person-group person-group-type="author"><name><surname>Leigh</surname><given-names>J</given-names></name><name><surname>Bowen</surname><given-names>S</given-names></name><name><surname>Marlatt</surname><given-names>GA</given-names></name></person-group><pub-id pub-id-type="doi">10.1016/j.addbeh.2005.01.010</pub-id><source>Addict Behav.</source><volume>30</volume><year>2005</year><pub-id pub-id-type="pmid">16022930</pub-id></element-citation></ref><ref id="A216REF11"><label>11</label><element-citation publication-type="journal" publication-format="print"><article-title>The role of mindfulness and psychological flexibility in somatization, depression, anxiety, and general psychological distress in a nonclinical college sample.</article-title><fpage>66</fpage><issue>1</issue><lpage>71</lpage><person-group person-group-type="author"><name><surname>Masuda</surname><given-names>A</given-names></name><name><surname>Tully</surname><given-names>EC</given-names></name></person-group><pub-id pub-id-type="doi">10.1177/2156587211423400</pub-id><source>J Evid Based Complementary Altern Med.</source><volume>17</volume><year>2012</year></element-citation></ref><ref id="A216REF12"><label>12</label><element-citation publication-type="journal" publication-format="print"><article-title>Effects of mindfulness based stress reduction program on depression, anxiety and stress in patients with aneurysmal subarachnoid hemorrhage.</article-title><fpage>345</fpage><issue>5</issue><lpage>51</lpage><person-group person-group-type="author"><name><surname>Joo</surname><given-names>HM</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name><name><surname>Chung</surname><given-names>YG</given-names></name><name><surname>Shin</surname><given-names>IY</given-names></name></person-group><pub-id pub-id-type="doi">10.3340/jkns.2010.47.5.345</pub-id><source>J Korean Neurosurg Soc.</source><volume>47</volume><year>2010</year><pub-id pub-id-type="pmid">20539793</pub-id></element-citation></ref><ref id="A216REF13"><label>13</label><element-citation publication-type="journal" publication-format="print"><article-title>Mindfulness to reduce psychosocial stress.</article-title><fpage>22</fpage><issue>1</issue><lpage>9</lpage><person-group person-group-type="author"><name><surname>Morone</surname><given-names>NE</given-names></name><name><surname>Lynch</surname><given-names>CP</given-names></name><name><surname>Losasso III</surname><given-names>VJ</given-names></name><name><surname>Liebe</surname><given-names>K</given-names></name><name><surname>Greco</surname><given-names>CM</given-names></name></person-group><pub-id pub-id-type="doi">10.1007/s12671-011-0076-z</pub-id><source>Mindfulness.</source><volume>3</volume><year>2012</year></element-citation></ref><ref id="A216REF14"><label>14</label><element-citation publication-type="journal" publication-format="print"><article-title>Depression, Stress, Anxiety and Mindfulness in Nursing Students.</article-title><fpage>397</fpage><issue>4</issue><lpage>402</lpage><person-group person-group-type="author"><name><surname>Song</surname><given-names>Y</given-names></name></person-group><source>Korean J Adult Nurs.</source><volume>23</volume><year>2011</year></element-citation></ref><ref id="A216REF15"><label>15</label><element-citation publication-type="journal" publication-format="print"><article-title>A randomized clinical trial of mindfulness-based cognitive therapy versus unrestricted services for health anxiety (hypochondriasis).</article-title><fpage>817</fpage><issue>5</issue><lpage>28</lpage><person-group person-group-type="author"><name><surname>McManus</surname><given-names>F</given-names></name><name><surname>Surawy</surname><given-names>C</given-names></name><name><surname>Muse</surname><given-names>K</given-names></name><name><surname>Vazquez-Montes</surname><given-names>M</given-names></name><name><surname>Williams</surname><given-names>JM</given-names></name></person-group><pub-id pub-id-type="doi">10.1037/a0028782</pub-id><source>J Consult Clin Psychol.</source><volume>80</volume><year>2012</year><pub-id pub-id-type="pmid">22708977</pub-id></element-citation></ref><ref id="A216REF16"><label>16</label><element-citation publication-type="journal" publication-format="print"><article-title>Cognitive processes mediate the relation between mindfulness and social anxiety within a clinical sample.</article-title><fpage>362</fpage><issue>3</issue><lpage>71</lpage><person-group person-group-type="author"><name><surname>Schmertz</surname><given-names>SK</given-names></name><name><surname>Masuda</surname><given-names>A</given-names></name><name><surname>Anderson</surname><given-names>PL</given-names></name></person-group><pub-id pub-id-type="doi">10.1002/jclp.20861</pub-id><source>J Clin Psychol.</source><volume>68</volume><year>2012</year><pub-id pub-id-type="pmid">22422563</pub-id></element-citation></ref><ref id="A216REF17"><label>17</label><element-citation publication-type="journal" publication-format="print"><article-title>Mindfulness-based cognitive therapy for generalized anxiety disorder.</article-title><fpage>716</fpage><issue>4</issue><lpage>21</lpage><person-group person-group-type="author"><name><surname>Evans</surname><given-names>S</given-names></name><name><surname>Ferrando</surname><given-names>S</given-names></name><name><surname>Findler</surname><given-names>M</given-names></name><name><surname>Stowell</surname><given-names>C</given-names></name><name><surname>Smart</surname><given-names>C</given-names></name><name><surname>Haglin</surname><given-names>D</given-names></name></person-group><pub-id pub-id-type="doi">10.1016/j.janxdis.2007.07.005</pub-id><source>J Anxiety Disord.</source><volume>22</volume><year>2008</year><pub-id pub-id-type="pmid">17765453</pub-id></element-citation></ref><ref id="A216REF18"><label>18</label><element-citation publication-type="journal" publication-format="print"><article-title>Mindfulness-based cognitive therapy in obsessive-compulsive disorder - a qualitative study on patients' experiences.</article-title><fpage>185</fpage><person-group person-group-type="author"><name><surname>Hertenstein</surname><given-names>E</given-names></name><name><surname>Rose</surname><given-names>N</given-names></name><name><surname>Voderholzer</surname><given-names>U</given-names></name><name><surname>Heidenreich</surname><given-names>T</given-names></name><name><surname>Nissen</surname><given-names>C</given-names></name><name><surname>Thiel</surname><given-names>N</given-names></name><etal>et al.</etal></person-group><pub-id pub-id-type="doi">10.1186/1471-244X-12-185</pub-id><source>BMC Psychiatry.</source><volume>12</volume><year>2012</year><pub-id pub-id-type="pmid">23114260</pub-id></element-citation></ref><ref id="A216REF19"><label>19</label><element-citation publication-type="journal" publication-format="print"><article-title>Mindfulness therapy for somatization disorder and functional somatic syndromes&#x02014;Randomized trial with one-year follow-up.</article-title><fpage>31</fpage><issue>1</issue><lpage>40</lpage><person-group person-group-type="author"><name><surname>Fjorback</surname><given-names>LO</given-names></name><name><surname>Arendt</surname><given-names>M</given-names></name><name><surname>Ornbol</surname><given-names>E</given-names></name><name><surname>Walach</surname><given-names>H</given-names></name><name><surname>Rehfeld</surname><given-names>E</given-names></name><name><surname>Schr&#x000f6;der</surname><given-names>A</given-names></name><etal>et al.</etal></person-group><source>J Psychosom Res.</source><volume>74</volume><year>2013</year><pub-id pub-id-type="pmid">23272986</pub-id></element-citation></ref><ref id="A216REF20"><label>20</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bowen</surname><given-names>S</given-names></name><name><surname>Chawala</surname><given-names>N</given-names></name><name><surname>Marlatt</surname><given-names>GA</given-names></name></person-group><publisher-loc>New York</publisher-loc><publisher-name>Guilford Press</publisher-name><source>Mindfulness-Based Relapse Pervention for Addictive Behaviors.</source><year>2011</year></element-citation></ref><ref id="A216REF21"><label>21</label><element-citation publication-type="journal" publication-format="print"><article-title>Mindfulness-based relapse prevention for substance use disorders: a pilot efficacy trial.</article-title><fpage>295</fpage><issue>4</issue><lpage>305</lpage><person-group person-group-type="author"><name><surname>Bowen</surname><given-names>S</given-names></name><name><surname>Chawla</surname><given-names>N</given-names></name><name><surname>Collins</surname><given-names>SE</given-names></name><name><surname>Witkiewitz</surname><given-names>K</given-names></name><name><surname>Hsu</surname><given-names>S</given-names></name><name><surname>Grow</surname><given-names>J</given-names></name><etal>et al.</etal></person-group><pub-id pub-id-type="doi">10.1080/08897070903250084</pub-id><source>Subst Abus.</source><volume>30</volume><year>2009</year><pub-id pub-id-type="pmid">19904665</pub-id></element-citation></ref><ref id="A216REF22"><label>22</label><element-citation publication-type="journal" publication-format="print"><article-title>Trait Mindfulness Predicts Attentional and Autonomic Regulation of Alcohol Cue-Reactivity.</article-title><fpage>180</fpage><issue>4</issue><lpage>9</lpage><person-group person-group-type="author"><name><surname>Garland</surname><given-names>EL</given-names></name></person-group><pub-id pub-id-type="doi">10.1027/0269-8803/a000060</pub-id><source>J Psychophysiol.</source><volume>25</volume><year>2011</year><pub-id pub-id-type="pmid">23976814</pub-id></element-citation></ref><ref id="A216REF23"><label>23</label><element-citation publication-type="journal" publication-format="print"><article-title>Mindfulness-Oriented Recovery Enhancement for Alcohol Dependence: Therapeutic Mechanisms and Intervention Acceptability.</article-title><fpage>242</fpage><issue>3</issue><lpage>63</lpage><person-group person-group-type="author"><name><surname>Garland</surname><given-names>EL</given-names></name><name><surname>Schwarz</surname><given-names>NM</given-names></name><name><surname>Kelly</surname><given-names>A</given-names></name><name><surname>Whitt</surname><given-names>A</given-names></name><name><surname>Howard</surname><given-names>MO</given-names></name></person-group><pub-id pub-id-type="doi">10.1080/1533256X.2012.702638</pub-id><source>J Soc Work Pract Addict.</source><volume>12</volume><year>2012</year><pub-id pub-id-type="pmid">23280067</pub-id></element-citation></ref><ref id="A216REF24"><label>24</label><element-citation publication-type="journal" publication-format="print"><article-title>Are mindfulness-based interventions effective for substance use disorders? A systematic review of the evidence.</article-title><fpage>492</fpage><issue>5</issue><lpage>512</lpage><person-group person-group-type="author"><name><surname>Chiesa</surname><given-names>A</given-names></name><name><surname>Serretti</surname><given-names>A</given-names></name></person-group><pub-id pub-id-type="doi">10.3109/10826084.2013.770027</pub-id><source>Subst Use Misuse.</source><volume>49</volume><year>2014</year><pub-id pub-id-type="pmid">23461667</pub-id></element-citation></ref><ref id="A216REF25"><label>25</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Ministry of Health and Medical Education</collab></person-group><publisher-loc>Tehran</publisher-loc><publisher-name>Ministry of Health and Medical Education</publisher-name><source>National Protocol for Treatment of Opioid Dependence with Opioid Agonist Medications Substance Abuse Prevention and Treatment Office (SAPTO), Bureau of Psychosocial Health and Addiction.</source><year>2006</year></element-citation></ref><ref id="A216REF26"><label>26</label><element-citation publication-type="journal" publication-format="print"><article-title>The Fifth Edition of the Addiction Severity Index.</article-title><fpage>199</fpage><issue>3</issue><lpage>213</lpage><person-group person-group-type="author"><name><surname>McLellan</surname><given-names>AT</given-names></name><name><surname>Kushner</surname><given-names>H</given-names></name><name><surname>Metzger</surname><given-names>D</given-names></name><name><surname>Peters</surname><given-names>R</given-names></name><name><surname>Smith</surname><given-names>I</given-names></name><name><surname>Grissom</surname><given-names>G</given-names></name><etal>et al.</etal></person-group><source>J Subst Abuse Treat.</source><volume>9</volume><year>1992</year><pub-id pub-id-type="pmid">1334156</pub-id></element-citation></ref><ref id="A216REF27"><label>27</label><element-citation publication-type="journal" publication-format="print"><article-title>Psychometric properties of the Penn Alcohol Craving Scale.</article-title><fpage>1289</fpage><issue>8</issue><lpage>95</lpage><person-group person-group-type="author"><name><surname>Flannery</surname><given-names>BA</given-names></name><name><surname>Volpicelli</surname><given-names>JR</given-names></name><name><surname>Pettinati</surname><given-names>HM</given-names></name></person-group><source>Alcohol Clin Exp Res.</source><volume>23</volume><year>1999</year><pub-id pub-id-type="pmid">10470970</pub-id></element-citation></ref><ref id="A216REF28"><label>28</label><element-citation publication-type="journal" publication-format="print"><article-title>Using self-report assessment methods to explore facets of mindfulness.</article-title><fpage>27</fpage><issue>1</issue><lpage>45</lpage><person-group person-group-type="author"><name><surname>Baer</surname><given-names>RA</given-names></name><name><surname>Smith</surname><given-names>GT</given-names></name><name><surname>Hopkins</surname><given-names>J</given-names></name><name><surname>Krietemeyer</surname><given-names>J</given-names></name><name><surname>Toney</surname><given-names>L</given-names></name></person-group><pub-id pub-id-type="doi">10.1177/1073191105283504</pub-id><source>Assessment.</source><volume>13</volume><year>2006</year><pub-id pub-id-type="pmid">16443717</pub-id></element-citation></ref><ref id="A216REF29"><label>29</label><element-citation publication-type="book"><edition>5th ed</edition><person-group person-group-type="author"><name><surname>Tabachnick</surname><given-names>BG</given-names></name><name><surname>Fidell</surname><given-names>LS</given-names></name></person-group><publisher-loc>New York</publisher-loc><publisher-name>HarperCollins</publisher-name><source>Using multivariate statistics.</source><year>2007</year></element-citation></ref><ref id="A216REF30"><label>30</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Joreskog</surname><given-names>KG</given-names></name><name><surname>Sorbom</surname><given-names>D</given-names></name></person-group><publisher-loc>Chicago</publisher-loc><publisher-name>Scientific Software, Inc.</publisher-name><source>LISREL 8: User's Reference Guide.</source><year>2003</year></element-citation></ref></ref-list></back></article>